title: Topotecan--a new treatment option in the therapy of brain metastases of lung cancer.
authors.affiliation: Städtisches Krankenhaus Martha-Maria, Halle, Germany.
authors.forename: W
authors.initials: W
authors.lastname: Schütte
authors.forename: C
authors.initials: C
authors.lastname: Manegold
authors.forename: J V
authors.initials: JV
authors.lastname: von Pawel
authors.forename: J
authors.initials: J
authors.lastname: Lan
authors.forename: B
authors.initials: B
authors.lastname: Schäfer
authors.forename: S
authors.initials: S
authors.lastname: Kaubitzsch
authors.forename: H J
authors.initials: HJ
authors.lastname: Staab
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001812:Blood-Brain Barrier; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000556:secondary*; D002986:Clinical Trials as Topic; D004791:Enzyme Inhibitors / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D019772:Topotecan / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D019772:Topotecan